In this issue:
Leukaemia selection:
Clonal haematopoiesis and blood cancer risk inferred from blood DNA
Age-related clonal haematopoiesis associated with adverse outcomes
Predicting NRM in RIC allogeneic SCT for AML in first CR
Lymphoma selection:
Factors delaying DLBCL diagnosis/treatment do not impact survival
Factors predicting survival in PTCL
Lenalidomide monotherapy for T-cell lymphoma
R-ACVBP vs. R-CHOP in non-GCB-like DLBCL
Rituximab optimisation in DLBCL
Nivolumab in relapsed/ refractory HL
Durable remissions with brentuximab in relapsed/ refractory HL
Please login below to download this issue (PDF)